DF/HCC Immunotherapy Toxicity SPORE RFPs
OCTOBER 22, 2019
The Cancer Immunology Program of the Dana-Farber/Harvard Cancer Center (DF/HCC) and the Department of Immunology in the Blavatnik Institute at Harvard Medical School (HMS) seek translational research projects for potential inclusion in a new Specialized Program on Research Excellence (SPORE) grant that will focus on Cancer Immunotherapy Related Toxicity. Applications are due on December 16th, 2019.
Proposals will be accepted from investigators from DF/HCC and HMS, although collaborative projects involving investigators from outside DF/HCC and HMS will be considered, as long as a DF/HCC or HMS-based investigator is involved. All basic research supported by the SPORE must have a plan for translation into application or studies in humans within the 5 years of the grant proposal.
|REQUEST FOR APPLICATIONS:||Immunotherapy Toxicity SPORE for Translational Research Projects|
|AWARD AMOUNT:||3 to 4 awards of $100,000-150,000 in yearly direct costs for 2-5 years|
|KEY DATES:|| |
Application Deadline: December 16th, 2019
Final Project Selection: February 29, 2020
Funding Begins: September 2020
We are seeking pre-applications in the form of a 2-4-page proposal that contains background and relevance, specific aims, research plan (preliminary data, experimental methods), anticipated timeline and plans for translation. Final project selections will be made by the Immunotherapy Toxicity SPORE Leadership Committee in conjunction with its Internal Advisory Board.
If the SPORE grant is funded, the project awards will be granted at a level of approximately $100,000-150,000 in yearly direct costs for 2-5 years. The awardees will be asked to apply for membership of the DF/HCC Cancer Immunology Program and will be expected to participate in SPORE activities (e.g. meetings, retreats, and research presentations). Women and underrepresented in medicine (URiM) investigators are encouraged to apply.
Application packages are due Monday December 16th, 2019 in PDF format.
Please contact Carolyn Hoban, ScD with any questions. Please send completed proposal electronically to CHOBAN@mgh.harvard.edu